MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway (Q39252620)

10 September 2017

MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway (English)

1 reference

10 September 2017

0 references

Hong-Sheng Zhang

1

1 reference

10 September 2017

Xin-Yu Chen

2

1 reference

10 September 2017

Tong-Chao Wu

3

1 reference

10 September 2017

Wei-Wei Sang

4

1 reference

10 September 2017

Zheng Ruan

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

24 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

586

1 reference

10 September 2017

23

1 reference

10 September 2017

4203-4207

1 reference

Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

The control of HIV transcription: keeping RNA polymerase II on track

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Chromatin dynamics associated with HIV-1 Tat-activated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

MicroRNAs in stress signaling and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

MicroRNAs and their potential involvement in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

The role of microRNAs in HIV-1 pathogenesis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

21 January 2018

MicroRNA-like antivirals

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Mini ways to stop a virus: microRNAs and HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

HIV-1 encoded candidate micro-RNAs and their cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Suppression of microRNA-silencing pathway by HIV-1 during virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Sirtuins mediate mammalian metabolic responses to nutrient availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Metabolic actions of hypothalamic SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Sirtuins and disease: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

The HIV-1 Tat protein has a versatile role in activating viral transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

SIRT1 longevity factor suppresses NF-κB -driven immune responses: regulation of aging via NF-κB acetylation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.023

10.1016/J.FEBSLET.2012.10.023

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference